Brilinta DaYu Study

Clinical trial NCT01870921 · COMPLETED

Trial details

NCT number: NCT01870921
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2013-06-26
Primary completion: 2015-09-30
Enrollment: 2004

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.